Transcriptomics

Dataset Information

3

Gene expression alterations in human colon cancer xenograft treated with anti-VEGF antibody


ABSTRACT: Recent randomized clinical trial revealed the additional effect of bevacizumab, a humanized monoclonal antibody against vascular endothelial growth factor (VEGF)-A, to conventional chemotherapy on survival of patients with metastatic colorectal cancer. However, a number of preclinical reports indicate resistant mechanisms to anti-angiogenic therapy in several tumor models. We investigated the phenotypic alterations of colorectal cancer xenograft during antiangiogenic therapy. TK-4, a solid tumor strain derived from human colon cancer, was orthotopically implanted into cecal walls of nude mice and treated with anti-VEGF antibody or control IgG for 35 days. Gene expression was analyzed using microarrays (Human Gene 1.0ST Array, Affymetrix).

REANALYSED by: E-GEOD-47087

ORGANISM(S): Homo sapiens  

SUBMITTER: Kyoko Kitagawa   Satoshi Baba  Masatoshi Kitagawa  Yoshihiro Hiramatsu  Manabu Ohta  Daniel C Chung  Takeshi Fujita  Takashi Uehara  Ichirota Iino  Kinji Kamiya  Shinichiro Miyazaki  Tomohiko Setoguchi  Hirotoshi Kikuchi  Hiroyuki Konno 

PROVIDER: E-GEOD-47087 | ArrayExpress | 2013-05-25

SECONDARY ACCESSION(S): GSE47087PRJNA203538

REPOSITORIES: GEO, ArrayExpress

Similar Datasets

2015-07-16 | E-GEOD-47087 | ExpressionAtlas
2013-07-01 | E-GEOD-45161 | ArrayExpress
2010-05-22 | E-GEOD-8821 | ArrayExpress
2010-07-16 | E-GEOD-17137 | ArrayExpress
2012-03-31 | E-GEOD-35314 | ArrayExpress
2013-06-26 | E-GEOD-43538 | ArrayExpress
2012-02-17 | E-GEOD-28691 | ArrayExpress
2012-06-06 | E-GEOD-35144 | ArrayExpress
| PRJNA318902 | ENA
2008-04-08 | E-GEOD-10358 | ArrayExpress